Switzerland - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases

Since 2014, Switzerland Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases jumped by 3.3% year on year. With 20 Cases in 2019, the country was ranked number 224 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo witnessed the best average annual growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.

Loading...

Date Units (Cases)
2019 20.00
2018 19.00
2017 19.00
2016 18.00
2015 16.00
Download all data from 2005 to 2019

How does Switzerland rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?

# 359 Countries Units (Cases) Last YoY 5‑years CAGR
1 #1
India
66,255 2019 +13.6 % +20.8 % View data
3 #3
Russia
29,181 2019 +5.0 % +13.4 % View data
223 #223
El Salvador
21 2019 +250.0 % +7.0 % View data
224 #224
Switzerland
20 2019 +5.3 % +3.3 % View data
226 #226
Tunisia
19 2019 +0.0 % +6.3 % View data
Compare all 359 countries

Go Top